Gamida Cel

$10.18
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.61 (+6.37%) Today
$0.00 (0.00%) As of 12:06 AM UTC after-hours

Why Robinhood?

You can buy or sell Gamida Cel and other stocks, options, and ETFs commission-free!

About GMDA

Gamida Cell Ltd. Ordinary Shares, also called Gamida Cel, is a clinical stage biopharmaceutical company engaging in the development of cell therapies to cure blood cancer and rare serious hematologic diseases. The company was founded by Tony Peled and Menashe Levy in 1998 and is headquartered in Jerusalem, Israel. The listed name for GMDA is Gamida Cell Ltd. Ordinary Shares.

CEO
Julian Adams
Employees
83
Headquarters
Jerusalem, Jerusalem
Founded
1998
Market Cap
660.50M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
2.90M
High Today
$10.38
Low Today
$9.79
Open Price
$9.99
Volume
595.97K
52 Week High
$15.00
52 Week Low
$2.60

GMDA Earnings

-$0.45
-$0.30
-$0.15
-$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 9, Pre-Market

You May Also Like

COOLU
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure